Members of Cornell’s Action Research Collaborative joined representatives from New York City agencies at a symposium Aug. 11 to discuss innovative new solutions aimed at dismantling the systemic racism that has led to inequities around food, nutrition, education, health and employment.
Jacob Anbinder, a Klarman postdoctoral fellow at Cornell University, researches how America’s most progressive cities become unaffordable for a significant portion of the population and the housing politics of prosperous metro areas. He says New York has a fundamental housing need: new homes now.
The Einhorn Center for Community Engagement announced two 2023 Community Work Study Program (CWSP) Student Employees of the Year. Sheryn Albayati ’23 received the off-campus award for her work with the Center for Transformative Action, and Hannah Rudt ’23 was the on-campus award recipient for her work with the Leak Research Group.
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.
New York City mayors past and present attended a celebration of the 10th anniversary of Cornell Tech, the technology and engineering-focused campus that Cornell launched in 2012 with its academic partner, the Technion-Israel Institute of Technology.
A preclinical study has shown that colorectal pre-cancerous lesions known as serrated polyps, and the aggressive tumors that develop from them, depend on the ramped-up production of cholesterol, which points to the possibility of using cholesterol-lowering drugs to prevent or treat such tumors.
The Samuel Curtis Johnson Graduate School of Management is offering qualified candidates who have been laid off by a U.S. tech company an application fee waiver and an application test waiver for the January 2023 deadline.
Removing race information from cardiovascular risk calculators – which predict the probability of developing heart disease – doesn’t affect patients’ risk scores, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
